{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:00:45Z","timestamp":1792130445045,"version":"4.4.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T00:00:00Z","timestamp":1576454400000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Migrants represent an increasing proportion of people living with HIV in many developed countries. We aimed to describe the HIV care cascade and baseline genotypic resistance for newly diagnosed asylum seekers referred to the McGill University Health Centre (MUHC) in Montreal, Quebec, Canada.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a retrospective cohort study of patients linked to the MUHC from June 1, 2017 to October 31, 2018. We calculated the median time (days; interquartile range (IQR)) from: 1) entry into Canada to immigration medical examination (IME) (i.e. HIV screening); 2) IME to patient notification of diagnosis; 3) notification to linkage to HIV care (defined as a CD4 or viral load (VL) measure); 4) linkage to HIV care to combination antiretroviral therapy (cART) prescription; and 5) cART prescription to viral suppression (defined as a VL\u2009&lt;\u200920 copies\/mL). We reviewed baseline genotypes and interpreted mutations using the Stanford University HIV Drug Resistance Database. We calculated the proportion with full resistance to\n                      <jats:underline>&gt;<\/jats:underline>\n                      \u20091 antiretroviral.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall, 43% (60\/139) of asylum seekers were newly diagnosed in Canada. Among these, 62% were late presenters (CD4\u2009&lt;\u2009350 cells\/\u03bcl), 22% presented with advanced HIV (CD4\u2009&lt;\u2009200 cells\/\u03bcl), and 25% with high-level viremia (VL\u2009&gt;\u2009100,000 copies\/ml). Median time from entry to IME: 27\u2009days [IQR:13;55]; IME to notification: 28\u2009days [IQR:21;49]; notification to linkage: 6\u2009days [IQR:2;19]; linkage to cART prescription: 11\u2009days [IQR:6;17]; and cART to viral suppression: 42\u2009days [IQR:31;88]; 45% were linked to HIV care within 30\u2009days. One-fifth (21%) had baseline resistance to at least one antiretroviral agent; the K103\u2009N\/S mutation was the most common mutation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>While the majority of newly diagnosed asylum seekers were late presenters, only 45% were linked to care within 30\u2009days. Once linked, care and viral suppression were rapid. Delays in screening and linkage to care present increased risk for onward transmission, and in the context of 21% baseline resistance, consideration of point-of-care testing and immediate referral at IME screening should be made.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-019-8052-y","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T13:03:00Z","timestamp":1576501380000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Delayed linkage to HIV care among asylum seekers in Quebec, Canada"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2724-0496","authenticated-orcid":false,"given":"Nadine","family":"Kronfli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blake","family":"Linthwaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Sheehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Lebouch\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"de Pokomandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Frenette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Roger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina B.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,16]]},"reference":[{"key":"8052_CR1","doi-asserted-by":"publisher","first-page":"e25123","DOI":"10.1002\/jia2.25123","volume":"21","author":"I Fakoya","year":"2018","unstructured":"Fakoya I, \u00c1lvarez-Del Arco D, Monge S, Copas AJ, Gennotte AF, Volny-Anne A, et al. HIV testing history and access to treatment among migrants living with HIV in Europe. J Int AIDS Soc. 2018;21:e25123 Available from: https:\/\/doi.org\/10.1002\/jia2.25123. [cited 2019 Aug 08].","journal-title":"J Int AIDS Soc"},{"issue":"2","key":"8052_CR2","doi-asserted-by":"publisher","first-page":"e0212268","DOI":"10.1371\/journal.pone.0212268","volume":"14","author":"P Gunaratnam","year":"2019","unstructured":"Gunaratnam P, Heywood AE, McGregor S, Jamil MS, McManus H, Mao L, et al. HIV diagnoses in migrant populations in Australia\u2014A changing epidemiology. PloS one. 2019;14(2):e0212268 Available from: https:\/\/doi.org\/10.1371\/journal.pone.0212268. [cited 2019 Aug 08].","journal-title":"PloS one"},{"key":"8052_CR3","volume-title":"Migrant health: epidemiology of HIV and AIDS in migrant communities and ethnic minorities in EU\/EEA countries: European centre for disease prevention and control (ECDC)","author":"J del Amo","year":"2010","unstructured":"del Amo J, P\u00e9rez-Cachafeiro S, Hernando V, Gonz\u00e1lez C, Jarr\u00ed I, Bol\u00famar F. Migrant health: epidemiology of HIV and AIDS in migrant communities and ethnic minorities in EU\/EEA countries: European centre for disease prevention and control (ECDC); 2010. Available from: https:\/\/ecdc.europa.eu\/sites\/portal\/files\/media\/en\/publications\/Publications\/0907_TER_Migrant_health_HIV_Epidemiology_review.pdf. [cited 2019 Mar 08]."},{"issue":"1","key":"8052_CR4","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1080\/13557858.2013.789829","volume":"19","author":"RC Mole","year":"2014","unstructured":"Mole RC, Parutis V, Gerry CJ, Burns FM. The impact of migration on the sexual health, behaviours and attitudes of Central and East European gay\/bisexual men in London. Ethn Health. 2014;19(1):86\u201399 Available from: https:\/\/doi.org\/10.1080\/13557858.2013.789829. [cited 2019 Aug 08].","journal-title":"Ethn Health"},{"issue":"10","key":"8052_CR5","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1097\/QAD.0000000000000724","volume":"29","author":"JE Pachankis","year":"2015","unstructured":"Pachankis JE, Hatzenbuehler ML, Hickson F, Weatherburn P, Berg RC, Marcus U, et al. Hidden from health: structural stigma, sexual orientation concealment, and HIV across 38 countries in the European MSM Internet Survey. AIDS (Lond, Engl). 2015;29(10):1239 Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4820755\/. [cited 2019 Aug 08].","journal-title":"AIDS (Lond, Engl)"},{"issue":"1","key":"8052_CR6","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1186\/s12889-015-1852-9","volume":"15","author":"I Fakoya","year":"2015","unstructured":"Fakoya I, \u00c1lvarez-del Arco D, Woode-Owusu M, Monge S, Rivero-Montesdeoca Y, Delpech V, et al. A systematic review of post-migration acquisition of HIV among migrants from countries with generalised HIV epidemics living in Europe: Implications for effectively managing HIV prevention programmes and policy. BMC Public Health. 2015;15(1):561 Available from: https:\/\/doi.org\/10.1186\/s12889-015-1852-9. [cited 2019 Aug 08].","journal-title":"BMC Public Health"},{"key":"8052_CR7","volume-title":"Immigrants, refugees and non-status people with HIV: Canadian AIDS Treatment Information Exchange (CATIE)","author":"A Li","year":"2009","unstructured":"Li A. Immigrants, refugees and non-status people with HIV: Canadian AIDS Treatment Information Exchange (CATIE); 2009. Available from: https:\/\/www.catie.ca\/en\/practical-guides\/managing-your-health\/17. [cited 2019 Mar 08]."},{"key":"8052_CR8","unstructured":"Government of Canada. Asylum claims by year \u2013 2011 - 2016: Canada.ca; c2018. Available from: https:\/\/www.canada.ca\/en\/immigration-refugees-citizenship\/services\/refugees\/asylum-claims\/processed-claims.html. [updated 2019 Feb 15; cited 2019 Mar 08]."},{"key":"8052_CR9","unstructured":"Government of Canada, Government of the United-States of America. Agreement between the Government of Canada and the Government of the United States of America for Cooperation in the Examination of Refugee Status Claims from Nationals of Third Countries: Canada.ca; 2002 . Available from: https:\/\/www.canada.ca\/en\/immigration-refugees-citizenship\/corporate\/mandate\/policies-operational-instructions-agreements\/agreements\/safe-third-country-agreement\/final-text.html. [updated 2016 Jun 23; cited 2019 Mar 08]."},{"key":"8052_CR10","unstructured":"Government of Canada. Who must submit to an immigration medical examination? : Canada.ca; c2018. Available from: https:\/\/www.canada.ca\/en\/immigration-refugees-citizenship\/corporate\/publications-manuals\/operational-bulletins-manuals\/standard-requirements\/medical-requirements\/exam\/who-must-submit-immigration-medical-examination.html. [updated 2017 Nov 10 cited 2019 Mar 08]"},{"issue":"12","key":"8052_CR11","doi-asserted-by":"publisher","first-page":"248","DOI":"10.14745\/ccdr.v43i12a01","volume":"43","author":"AC Bourgeois","year":"2017","unstructured":"Bourgeois AC, Edmunds M, Awan A, Jonah L, Varsaneux O, Siu W-K. HIV in Canada-Surveillance Report, 2016. Can Commun Dis Rep. 2017;43(12):248\u201356 Available from: https:\/\/dx.doi.org\/10.14745%2Fccdr.v44i12a03. [cited 2019 Aug 08].","journal-title":"Can Commun Dis Rep"},{"key":"8052_CR12","unstructured":"Government of Canada. Interim Federal Health Program: Summary of coverage: Canada.ca; c2018. Available from: https:\/\/www.canada.ca\/en\/immigration-refugees-citizenship\/services\/refugees\/help-within-canada\/health-care\/interim-federal-health-program\/coverage-summary.html. [updated 2018 Oct 12; cited 2019 Mar 08]."},{"issue":"12","key":"8052_CR13","doi-asserted-by":"publisher","first-page":"324","DOI":"10.14745\/ccdr.v44i12a03","volume":"44","author":"N Haddad","year":"2018","unstructured":"Haddad N, Li J, Totten S, McGuire M. HIV in Canada\u2013Surveillance Report, 2017. Can Commun Dis Rep. 2018;44(12):324\u201332 Available from: https:\/\/doi.org\/10.14745\/ccdr.v44i12a03. [cited 2019 Aug 08].","journal-title":"Can Commun Dis Rep"},{"key":"8052_CR14","unstructured":"Joint United Nations Programme on HIV\/AIDS. 90-90-90: an ambitious treatment target to help end the AIDS epidemic: UNAIDS 2014. Available from: http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/90-90-90_en.pdf. [cited 2019 Mar 08]"},{"key":"8052_CR15","unstructured":"Centers for Disease Control and Prevention (CDC). Understanding the HIV Care Continuum: CDC 2018. Available from: https:\/\/www.cdc.gov\/hiv\/pdf\/library\/factsheets\/cdc-hiv-care-continuum.pdf. [cited 2019 Mar 08]."},{"issue":"7","key":"8052_CR16","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/hiv.12476","volume":"18","author":"K O'Laughlin","year":"2017","unstructured":"O'Laughlin K, Kasozi J, Rabideau D, Parker R, Mulogo E, Faustin Z, et al. The cascade of HIV care among refugees and nationals in Nakivale Refugee Settlement in Uganda. HIV Med. 2017;18(7):513\u20138 Available from: https:\/\/doi.org\/10.1111\/hiv.12476. [cited 2019 Aug 08].","journal-title":"HIV Med"},{"key":"8052_CR17","unstructured":"Stanford HIV Drug resistance database. Available from: https:\/\/hivdb.stanford.edu\/. [cited 2019 Mar 08]"},{"issue":"7","key":"8052_CR18","doi-asserted-by":"publisher","first-page":"e11505","DOI":"10.1371\/journal.pone.0011505","volume":"5","author":"D Frentz","year":"2010","unstructured":"Frentz D, Boucher CA, Assel M, De Luca A, Fabbiani M, Incardona F, et al. Comparison of HIV-1 genotypic resistance test interpretation systems in predicting virological outcomes over time. PloS one. 2010;5(7):e11505 Available from: https:\/\/doi.org\/10.1371\/journal.pone.0011505. [cited 2019 Aug 08].","journal-title":"PloS one"},{"issue":"5","key":"8052_CR19","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/hiv.12600","volume":"19","author":"L Ryom","year":"2018","unstructured":"Ryom L, Boesecke C, Bracchi M, Ambrosioni J, Pozniak A, Arribas J, et al. Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV-positive persons version 9.0. HIV Med. 2018;19(5):309\u201315 Available from: https:\/\/doi.org\/10.1111\/hiv.12600. [cited 2019 Aug 08].","journal-title":"HIV Med"},{"issue":"1","key":"8052_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/QCO.0000000000000415","volume":"31","author":"J Ross","year":"2018","unstructured":"Ross J, Cunningham CO, Hanna DB. HIV outcomes among migrants from low-income and middle-income countries living in high-income countries: A review of recent evidence. Curr Opin Infect Dis. 2018;31(1):25\u201332 Available from: https:\/\/europepmc.org\/articles\/pmc5750122. [cited 2019 Aug 08].","journal-title":"Curr Opin Infect Dis"},{"issue":"1","key":"8052_CR21","doi-asserted-by":"publisher","first-page":"e009688","DOI":"10.1136\/bmjopen-2015-009688","volume":"6","author":"EL Op de Coul","year":"2016","unstructured":"Op de Coul EL, Van Sighem A, Brinkman K, van Benthem BH, van der Ende ME, Geerlings S, et al. Factors associated with presenting late or with advanced HIV disease in the Netherlands, 1996\u20132014: results from a national observational cohort. BMJ Open. 2016;6(1):e009688 Available from: http:\/\/dx.doi.org\/10.1136\/bmjopen-2015-009688. [cited 2019 Aug 08].","journal-title":"BMJ Open"},{"issue":"2","key":"8052_CR22","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1097\/QAI.0000000000000717","volume":"70","author":"V Hernando","year":"2015","unstructured":"Hernando V, Alv\u00e1rez-del Arco D, Alejos B, Monge S, Amato-Gauci AJ, Noori T, et al. HIV infection in migrant populations in the European Union and European Economic Area in 2007\u20132012: An epidemic on the move. J Acquir Immune Defic Syndr. 2015;70(2):204\u201311 Available from: https:\/\/journals.lww.com\/jaids\/fulltext\/2015\/10010\/HIV_Infection_in_Migrant_Populations_in_the.14.aspx. [cited 2019 Aug 08].","journal-title":"J Acquir Immune Defic Syndr"},{"key":"8052_CR23","unstructured":"Government of Canada. Medical exam for permanent residents: Canada.ca; c2018. Available from: https:\/\/www.canada.ca\/en\/immigration-refugees-citizenship\/services\/application\/medical-police\/medical-exams\/requirements-permanent-residents.html. [updated 2019 Jan 25; cited 2019 Mar 08]."},{"issue":"4","key":"8052_CR24","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.2196\/publichealth.7741","volume":"3","author":"Ibidun Fakoya","year":"2017","unstructured":"Fakoya I, \u00c1lvarez-del Arco D, Copas AJ, Teixeira B, Block K, Gennotte A-F, et al. Factors associated with access to HIV testing and primary care among migrants living in Europe: cross-sectional survey. JMIR Public Health Surveill. 2017;3(4) Available from: https:\/\/doi.org\/10.2196\/publichealth.7741. [cited 2019 Aug 08].","journal-title":"JMIR Public Health and Surveillance"},{"issue":"10","key":"8052_CR25","doi-asserted-by":"publisher","first-page":"e109420","DOI":"10.1371\/journal.pone.0109420","volume":"9","author":"H Charest","year":"2014","unstructured":"Charest H, Doualla-Bell F, Cantin R, Murphy DG, Lemieux L, Brenner B, et al. A significant reduction in the frequency of HIV-1 drug resistance in Quebec from 2001 to 2011 is associated with a decrease in the monitored viral load. PloS one. 2014;9(10):e109420 Available from: https:\/\/doi.org\/10.1371\/journal.pone.0109420. [cited 2019 Aug 08].","journal-title":"PloS one"},{"key":"8052_CR26","unstructured":"Public Health Agency of Canada (PHAC). Update on HIV-1 Strain and Transmitted Drug Resistance in Canada: 2012-2013: Centre for Communicable Diseases and Infection Control - Public Health Agency of Canada,; 2017. Available from: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/diseases-conditions\/hiv-canadian-strain-drug-resistance-surveillance-2012-2013.html. [cited 8 March 2019]."},{"key":"8052_CR27","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV: US Department of Health and Human Services (DHHS); 2018 . Available from: http:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/AdultandAdolescentGL.pdf. [updated 25 Oct 2018; cited 8 Mar 2019]."}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-019-8052-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12889-019-8052-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-019-8052-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T19:10:46Z","timestamp":1607973046000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-019-8052-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["8052"],"URL":"https:\/\/doi.org\/10.1186\/s12889-019-8052-y","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"13 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Research Institute of the McGill University Health Centre Research Ethics Board (MUHC 2019\u20135037). Given the retrospective nature of the study, patient consent was not obtained.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. All our data are anonymised. We have removed any specific contextual identifiers and used systematic codes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of the authors feel in conflict of interest with regards to this study and there was no pharmaceutical industry support to conduct this study. Blake Linthwaite, Nancy Sheehan, Isabelle Hardy, Charles Frenette and Michel Roger have no conflicts of interest to declare. Nadine Kronfli has received consulting fees from ViiV Healthcare, Merck and Gilead; research funding from Gilead; and payment for lectures from Gilead. Joseph Cox has received consulting fees from ViiV Healthcare and Gilead; research funding from ViiV Healthcare, Merck and Gilead; and payment for lectures from Gilead. Bertrand Lebouch\u00e9 has received consulting fees from ViiV Healthcare, Merck and Gilead; research funding from Merck, Gilead and Abbvie; and payment for lectures from Merck and Gilead. Alexandra de Pokomandy has received consulting fees from ViiV Healthcare. Marina B. Klein has received consulting fees from ViiV Healthcare, BMS, Merck, Gilead and AbbVie; and research funding from Merck, Gilead and ViiV Healthcare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1683"}}